Radiotherapy for throat cancer in China — get 3 personalized clinic matches
Bookimed lists 2 radiotherapy for throat cancer clinics in China, all in Guangzhou. These clinics are rated 4.6/5 in 19 verified patient reviews on Bookimed.
Medically reviewed by
Yesim Yildirim
How it works
How Much Does Radiotherapy for throat cancer Cost in China?
Radiotherapy for throat cancer in China typically costs from $14,000 to $31,000. Final pricing depends on the radiation technique, hospital tier, and the number of fractions required. Patients save around 50% compared to the US, where this procedure costs $45,000 on average. Chinese medical packages often include airport transfers, professional interpreters, and comprehensive treatment planning.
- Hospital tier: Grade III, Class-A public hospitals offer systematic pricing for international patients.
- Advanced technologies: Tomotherapy and TrueBeam systems typically cost more than standard linear accelerators.
- Particle therapy: Specialized proton-beam therapy can increase the total cost by 50-70%.
- Geographic location: Medical hubs like Guangzhou and Chengdu are primary destinations for oncology care.
Bookimed Expert Insight: China offers high-value oncology care at JCI-accredited facilities like Fuda Cancer Hospital. Treatment here typically runs 2–3 times lower than in Western Europe. Leading specialists, such as Dr. Zhang Yanjun, often have US-based training in advanced radiation oncology. Patients benefit from modern facilities like Jinshazhou Hospital, which maintains OECI certification and 1,200 beds. Choosing these specialized centers ensures access to international standards at a significantly lower price point.
| China | Turkey | Austria | |
|---|---|---|---|
| Radiotherapy for throat cancer | ≈ $14,000 | from $6,000 | from $6,600 |
Discover the Best Radiotherapy for throat cancer Clinics in China: 2 Verified Options and Prices
Jinshazhou Hospital of Guangzhou University of Chinese Medicine
Zhang Yanjun
Radiotherapy for throat cancer Overview in China
- Radiotherapy - from $8,000This therapy uses high-energy waves to destroy cancer cells, providing a non-surgical treatment with few side effects.
- Stereotaxic radiosurgery - from $10,800This therapy targets tumors with precise radiation, avoiding damage to surrounding tissues.
- Radiation therapy for brain tumor - from $6,700This therapy aims to destroy brain tumors using high-energy rays, reducing symptoms and improving survival rates.
- Radiotherapy for prostate cancer - from $10,000This therapy targets prostate tumors with radiation, annihilating cancer cells while preserving healthy tissue.
- Radiotherapy for lung cancer - from $7,000This therapy aims to kill cancer cells in the lungs using high-energy x-rays.
Day 1
- Arrive at the hospital.
- Consult with your oncologist.
- Undergo a physical examination.
Day 2
- Complete blood tests.
- Take imaging tests like CT or PET scans.
Day 3
- Undergo a biopsy if necessary.
- Discuss results and treatment plan with oncologist.
Day 4
- Customized mask for radiotherapy is prepared.
- Simulation of radiotherapy process is done.
Week 1 - Week 7
- Undergo daily radiotherapy sessions (30 minutes each).
- Regular check-ups with oncologist.
- Adjustments made to treatment plan if needed.
Week 8
- Post-treatment consultation with oncologist.
- Assessment of treatment response through tests.
Week 9 - Week 12
- Begin rehabilitation with speech and swallowing therapy.
- Attend regular follow-up appointments.
Week 13 onwards
- Gradual return to work and normal activities.
- Continue regular medical check-ups.
Please note, each patient"s treatment plan and recovery timeline may vary based on the severity of the illness, overall health condition, and response to treatment.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Trusted Doctors
View all Doctors
Liao Zhengyin
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
Zhang Yanjun
30 years specializing in tumor imaging and radiotherapy – Dr. Zhang Yanjun brings deep expertise to throat cancer treatment at Jinshazhou Hospital.
- Member of China's National Digestive Oncology Expert Committee
- Trained at leading US cancer radiation therapy hospitals
- Published 46 papers on tumor diagnosis and treatment
- Expert in stereotactic radiation therapy techniques
Luo Xiaoping
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).
He Weibing
Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.
He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviews
Share this content
Anna Leonova